#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transient ischaemic attack Indolent systemic mastocytosis Idiopathic pulmonary fibrosis Pouchitis Cataract Dedifferentiated liposarcoma Rhabdomyosarcoma recurrent Congenital aplastic anaemia Myeloid leukaemia Phenylketonuria Arterial tortuosity syndrome Bronchopulmonary aspergillosis Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Spinal cord injury Von Hippel-Lindau disease More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Life with Disease Adrenogenital syndrome – Basic Information Primary mediastinal large B-cell lymphoma – Diagnostics Pleomorphic leiomyosarcoma – Trials in Disease Epidermolysis bullosa Ornithine transcarbamoylase deficiency Advanced systemic mastocytosis Primary biliary cholangitis – Basic Information KBG syndrome – Diagnostics Pelizaeus-Merzbacher disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Miglustat Mifepristone Prednisolone Sodium Succinate Mk-1088 Mepivacaine Hydrochloride Fondaparinux Sodium Ciprofloxacin Setrusumab ANTIMETABOLITES Zamtocabtagene Autoleucel Calcium Pantothenate Bp Neflamapimod Sabatolimab Quetiapine YOHIMBINE HYDROCHLORIDE Annamycin Histidine Tofersen Eculizumab 177LU-FAP-2286 More therapies…

    Learn about Your Condition

    Breast cancer male Head injury Polycystic liver disease Septic shock Pancreaticoduodenectomy Neurodermatitis Nasopharyngeal cancer Embolism venous Lymphangioleiomyomatosis Mitral valve incompetence K-ras gene mutation Breast cancer recurrent Leiomyosarcoma metastatic Tardive dyskinesia Vulval cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mlpoen Zlqufwgk Kfywz 2au Dsdignetc 4jlam Huomuks

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Belzutifan
    • Pembrolizumab
    Bulgaria Czechia Finland France Germany Greece +8

  • Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia Estonia France Germany +10

  • Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tanimilast
    Bulgaria Czechia Germany Hungary Italy Latvia +4

  • Study on the Accuracy of OWL-EVO1 Test for Diagnosing Lung Cancer in Patients Eligible for Screening or with Suspicious CT Findings

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Adenosquamous cell lung cancer recurrent
    • Adenosquamous cell lung cancer stage 0
    • Adenosquamous cell lung cancer stage I
    Investigated Drugs:
    • D5-Ethyl-Beta-D-Glucuronide
    Czechia Hungary

  • Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Bulgaria Czechia Germany Greece Hungary Italy +5

  • Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Doxorubicin
    • Paclitaxel
    • Pembrolizumab
    Belgium France Germany Hungary Ireland Poland +2

  • Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma urethra
    • Transitional cell cancer of the renal pelvis and ureter
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Enfortumab Vedotin
    • Carboplatin
    • Cisplatin
    Belgium Czechia Denmark France Germany Hungary +4

  • Study on Izokibep for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Izokibep
    France Germany Hungary Poland Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 for Treating Plaque Psoriasis in Special Areas for Patients with Moderate to Severe Symptoms

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Jnj-77242113
    Germany Hungary Poland Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Mercaptopurine
    • Azathioprine
    • Jnj-77242113
    Belgium Czechia France Germany Hungary Italy +3
Previous Page
1 … 42 43 44 45 46 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!